Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun 16;11(6):809.
doi: 10.3390/antibiotics11060809.

Epigenetic-Mediated Antimicrobial Resistance: Host versus Pathogen Epigenetic Alterations

Jibran Sualeh Muhammad  1 , Naveed Ahmed Khan  1 , Sutherland K Maciver  2 , Ahmad M Alharbi  3 , Hasan Alfahemi  4 , Ruqaiyyah Siddiqui  5
Affiliations
Review

Epigenetic-Mediated Antimicrobial Resistance: Host versus Pathogen Epigenetic Alterations

Jibran Sualeh Muhammad et al. Antibiotics (Basel). .

Abstract

Since the discovery of antibiotics, humans have been benefiting from them by decreasing the morbidity and mortality associated with bacterial infections. However, in the past few decades, misuse of antibiotics has led to the emergence of bacterial infections resistant to multiple drugs, a significant health concern. Bacteria exposed to inappropriate levels of antibiotics lead to several genetic changes, enabling them to survive in the host and become more resistant. Despite the understanding and targeting of genetic-based biochemical changes in the bacteria, the increasing levels of antibiotic resistance are not under control. Many reports hint at the role of epigenetic modifications in the bacterial genome and host epigenetic reprogramming due to interaction with resistant pathogens. Epigenetic changes, such as the DNA-methylation-based regulation of bacterial mutation rates or bacteria-induced histone modification in human epithelial cells, facilitate its long-term survival. In this review article, epigenetic changes leading to the development of antibiotic resistance in clinically relevant bacteria are discussed. Additionally, recent lines of evidence focusing on human host epigenetic changes due to the human-pathogen interactions are presented. As genetic mechanisms cannot explain the transient nature of antimicrobial resistance, we believe that epigenetics may provide new frontiers in antimicrobial discovery.

Keywords: DNA methylation; HU proteins; antibiotic resistance; epigenetic changes; histone modifications; nucleoid-associated proteins.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flowchart outlining the strategy employed to identify the relevant studies.
Figure 2
Figure 2
(A) Eukaryotic histones (green) have lysine-rich tails that are acetylated by lysine acetyltransferases, and this result in a reduction in affinity of the histone for DNA; (B) the histone-like protein (HU) (blue) of Mycobacterium also has a tail that is rich in lysines, which is acetylated by Eis, leading to a reduction in DNA affinity; (C) other bacterial HUs do not have tails but are acetylated at other positions to reduce their affinity to DNA.
Figure 3
Figure 3
Bacteria-mediated epigenetic alterations in human host cells.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Kollef M.H., Bassetti M., Francois B., Burnham J., Dimopoulos G., Garnacho-Montero J., Lipman J., Luyt C.E., Nicolau D.P., Postma M.J., et al. The intensive care medicine research agenda on multidrug-resistant bacteria, antibiotics, and stewardship. Intensive Care Med. 2017;43:1187–1197. doi: 10.1007/s00134-017-4682-7. - DOI - PMC - PubMed
    1. Antimicrobial Resistance Collaborators Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet. 2022;399:629–655. doi: 10.1016/S0140-6736(21)02724-0. - DOI - PMC - PubMed
    1. Bassetti M., Poulakou G., Timsit J.F. Focus on antimicrobial use in the era of increasing antimicrobial resistance in ICU. Intensive Care Med. 2016;42:955–958. doi: 10.1007/s00134-016-4341-4. - DOI - PubMed
    1. Jasovsky D., Littmann J., Zorzet A., Cars O. Antimicrobial resistance-a threat to the world‘s sustainable development. Ups. J. Med. Sci. 2016;121:159–164. doi: 10.1080/03009734.2016.1195900. - DOI - PMC - PubMed
    1. Magiorakos A.P., Srinivasan A., Carey R.B., Carmeli Y., Falagas M.E., Giske C.G., Harbarth S., Hindler J.F., Kahlmeter G., Olsson-Liljequist B., et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 2012;18:268–281. doi: 10.1111/j.1469-0691.2011.03570.x. - DOI - PubMed